GB0723712D0 - Peptides - Google Patents

Peptides

Info

Publication number
GB0723712D0
GB0723712D0 GBGB0723712.6A GB0723712A GB0723712D0 GB 0723712 D0 GB0723712 D0 GB 0723712D0 GB 0723712 A GB0723712 A GB 0723712A GB 0723712 D0 GB0723712 D0 GB 0723712D0
Authority
GB
United Kingdom
Prior art keywords
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0723712.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apitope Technology Bristol Ltd
Original Assignee
Apitope Technology Bristol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Technology Bristol Ltd filed Critical Apitope Technology Bristol Ltd
Priority to GBGB0723712.6A priority Critical patent/GB0723712D0/en
Publication of GB0723712D0 publication Critical patent/GB0723712D0/en
Priority to UAA201008194A priority patent/UA101003C2/uk
Priority to CA3005013A priority patent/CA3005013C/en
Priority to EP08855772.3A priority patent/EP2227488B3/en
Priority to HRP20140344TT priority patent/HRP20140344T4/hr
Priority to PL08855772T priority patent/PL2227488T6/pl
Priority to MX2010006084A priority patent/MX2010006084A/es
Priority to BRPI0820143 priority patent/BRPI0820143A2/pt
Priority to JP2010536523A priority patent/JP5501245B2/ja
Priority to KR1020107011743A priority patent/KR101519840B1/ko
Priority to HK10110866.8A priority patent/HK1144292B/en
Priority to ES08855772.3T priority patent/ES2458315T7/es
Priority to CA2707559A priority patent/CA2707559C/en
Priority to NZ585217A priority patent/NZ585217A/xx
Priority to EA201070681A priority patent/EA019370B1/ru
Priority to US12/746,141 priority patent/US8445448B2/en
Priority to CN201310392152.6A priority patent/CN103709234B/zh
Priority to CN200880119313.1A priority patent/CN101889024B/zh
Priority to MYPI20102567 priority patent/MY150995A/en
Priority to PT88557723T priority patent/PT2227488E/pt
Priority to PCT/GB2008/003996 priority patent/WO2009071886A1/en
Priority to SI200831186T priority patent/SI2227488T1/sl
Priority to AU2008332968A priority patent/AU2008332968B2/en
Priority to DK08855772.3T priority patent/DK2227488T6/en
Priority to ZA2010/02997A priority patent/ZA201002997B/en
Priority to IL205780A priority patent/IL205780A/en
Priority to EC2010010327A priority patent/ECSP10010327A/es
Priority to JP2014023217A priority patent/JP6063402B2/ja
Priority to CY20141100281T priority patent/CY1115168T1/el
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0723712.6A 2007-12-04 2007-12-04 Peptides Ceased GB0723712D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GBGB0723712.6A GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides
UAA201008194A UA101003C2 (uk) 2007-12-04 2008-03-12 Пептид фактора fviii та його застосування для індукції толерантності у хворих гемофілією
DK08855772.3T DK2227488T6 (en) 2007-12-04 2008-12-03 FVIII PEPTIDES AND THEIR USE for inducing tolerance in hemophilic
EA201070681A EA019370B1 (ru) 2007-12-04 2008-12-03 Пептиды fviii и их применение для индукции толерантности у больных гемофилией
US12/746,141 US8445448B2 (en) 2007-12-04 2008-12-03 FVIII peptides and their use in tolerising haemophiliacs
HRP20140344TT HRP20140344T4 (hr) 2007-12-04 2008-12-03 Fviii peptidi i njihova uporaba u lijeäśenju hemofilije
PL08855772T PL2227488T6 (pl) 2007-12-04 2008-12-03 FVIII Peptydy i ich zastosowanie w indukcji tolerancji u chorych na hemofilię
MX2010006084A MX2010006084A (es) 2007-12-04 2008-12-03 Peptidos del factor viii y su uso en la tolerizacion de hemofilicos.
BRPI0820143 BRPI0820143A2 (pt) 2007-12-04 2008-12-03 Peptideos de fviii e seu uso em tolerização de hemofílicos
JP2010536523A JP5501245B2 (ja) 2007-12-04 2008-12-03 Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用
KR1020107011743A KR101519840B1 (ko) 2007-12-04 2008-12-03 Ｆⅷ 펩타이드 및 혈우병 환자 내성화시 그의 용도
HK10110866.8A HK1144292B (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
ES08855772.3T ES2458315T7 (es) 2007-12-04 2008-12-03 Péptidos de FVIII y su uso en la inducción de tolerancia en pacientes hemofílicos
CA2707559A CA2707559C (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
NZ585217A NZ585217A (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
CA3005013A CA3005013C (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
EP08855772.3A EP2227488B3 (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
CN201310392152.6A CN103709234B (zh) 2007-12-04 2008-12-03 Fviii 肽和它们用于耐受化血友病患者的用途
CN200880119313.1A CN101889024B (zh) 2007-12-04 2008-12-03 Fviii肽和它们用于耐受化血友病患者的用途
MYPI20102567 MY150995A (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
PT88557723T PT2227488E (pt) 2007-12-04 2008-12-03 Péptidos fviii e seu uso na tolerização de hemofílicos
PCT/GB2008/003996 WO2009071886A1 (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
SI200831186T SI2227488T1 (sl) 2007-12-04 2008-12-03 FVIII peptidi in njihova uporaba pri toleriziranju hemofilikov
AU2008332968A AU2008332968B2 (en) 2007-12-04 2008-12-03 FVIII peptides and their use in tolerising haemophiliacs
ZA2010/02997A ZA201002997B (en) 2007-12-04 2010-04-29 Fvii peptides and their use in tolerising haemophiliacs
IL205780A IL205780A (en) 2007-12-04 2010-05-13 Synthetic peptides capable of suppressing intravenous production of anti-factor inhibitors viii
EC2010010327A ECSP10010327A (es) 2007-12-04 2010-07-02 Péptidos del fviii y su uso para hemofílicos tolerantes
JP2014023217A JP6063402B2 (ja) 2007-12-04 2014-02-10 Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用
CY20141100281T CY1115168T1 (el) 2007-12-04 2014-04-15 Πεπτιδια fviii και η χρηση τους στην επαγωγη ανοχης των αιμορροφιλικων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0723712.6A GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides

Publications (1)

Publication Number Publication Date
GB0723712D0 true GB0723712D0 (en) 2008-01-16

Family

ID=38982965

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0723712.6A Ceased GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides

Country Status (25)

Country Link
US (1) US8445448B2 (enExample)
EP (1) EP2227488B3 (enExample)
JP (2) JP5501245B2 (enExample)
KR (1) KR101519840B1 (enExample)
CN (2) CN103709234B (enExample)
AU (1) AU2008332968B2 (enExample)
BR (1) BRPI0820143A2 (enExample)
CA (2) CA2707559C (enExample)
CY (1) CY1115168T1 (enExample)
DK (1) DK2227488T6 (enExample)
EA (1) EA019370B1 (enExample)
EC (1) ECSP10010327A (enExample)
ES (1) ES2458315T7 (enExample)
GB (1) GB0723712D0 (enExample)
HR (1) HRP20140344T4 (enExample)
IL (1) IL205780A (enExample)
MX (1) MX2010006084A (enExample)
MY (1) MY150995A (enExample)
NZ (1) NZ585217A (enExample)
PL (1) PL2227488T6 (enExample)
PT (1) PT2227488E (enExample)
SI (1) SI2227488T1 (enExample)
UA (1) UA101003C2 (enExample)
WO (1) WO2009071886A1 (enExample)
ZA (1) ZA201002997B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030062321A (ko) 2000-08-21 2003-07-23 아피토프 테크놀러지 (브리스톨) 리미티드 펩티드 선별 방법
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
US8329871B2 (en) * 2008-06-24 2012-12-11 Octapharma Ag Process of purifying coagulation factor VIII
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
US20120135917A1 (en) * 2009-06-16 2012-05-31 Eisaku Yoshihara Anti-Gram Negative Bacteria Agent
PL3260132T3 (pl) * 2010-10-27 2022-08-08 Takeda Pharmaceutical Company Limited Peptydy fviii do wywoływania tolerancji immunologicznej oraz immunodiagnostyki
EA038705B1 (ru) 2012-01-12 2021-10-07 Биовератив Терапьютикс Инк. Способы снижения иммуногенности фактора свёртывания крови viii у пациентов, получающих лечение фактором viii
CN104903347B (zh) * 2012-11-12 2020-02-21 艾匹托普国际股份有限公司 肽
GB201314052D0 (en) 2013-08-06 2013-09-18 Apitope Int Nv Peptides
MX2018006789A (es) 2015-12-03 2019-02-13 Juno Therapeutics Inc Receptores quimericos modificados y composiciones y metodos relacionados.
CA3044838A1 (en) 2016-12-02 2018-06-07 Bioverativ Therapeutics Inc. Methods of inducing immune tolerance to clotting factors
US12077607B2 (en) * 2021-09-23 2024-09-03 University Of Utah Research Foundation Functional and therapeutic effects of PAR4 cleavage by cathepsin G

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015615A1 (en) * 1989-06-20 1990-12-27 Scripps Clinic And Research Foundation The phospholipid binding domain of factor viii
US6132729A (en) * 1997-01-22 2000-10-17 Board Of Regents, The University Of Texas System Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment
KR20030062321A (ko) 2000-08-21 2003-07-23 아피토프 테크놀러지 (브리스톨) 리미티드 펩티드 선별 방법
US20040096456A1 (en) * 2000-12-01 2004-05-20 Conti-Fine Bianca M Method to treat hemophilia
PL362324A1 (en) * 2001-02-19 2004-10-18 Merck Patent Gmbh Artificial fusion proteins with reduced immunogenicity
AU2002312660A1 (en) * 2001-05-31 2002-12-16 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
MXPA04010061A (es) * 2002-04-18 2004-12-13 Merck Patent Gmbh Factor viii modificado.
CN102816241B (zh) * 2004-02-09 2015-07-22 人类基因科学公司 清蛋白融合蛋白
WO2006003183A1 (de) 2004-07-02 2006-01-12 Alois Jungbauer Peptide zur blockierung von fviii-inhibitoren
IL229645A0 (en) * 2013-11-26 2014-03-31 Omrix Biopharmaceuticals Ltd A dry bandage containing thrombin and pectin

Also Published As

Publication number Publication date
BRPI0820143A2 (pt) 2015-05-12
ZA201002997B (en) 2011-07-27
CN101889024B (zh) 2014-04-23
JP6063402B2 (ja) 2017-01-18
JP2014088440A (ja) 2014-05-15
NZ585217A (en) 2012-11-30
CA3005013C (en) 2021-11-16
CA2707559C (en) 2018-07-03
UA101003C2 (uk) 2013-02-25
PL2227488T3 (pl) 2014-07-31
ES2458315T3 (es) 2014-04-30
ECSP10010327A (es) 2010-09-30
SI2227488T1 (sl) 2014-06-30
CN103709234B (zh) 2017-01-18
AU2008332968B2 (en) 2014-03-20
EA201070681A1 (ru) 2010-10-29
IL205780A0 (en) 2010-11-30
EP2227488B1 (en) 2014-01-22
CA3005013A1 (en) 2009-06-11
PL2227488T6 (pl) 2015-04-30
MX2010006084A (es) 2010-06-23
MY150995A (en) 2014-03-31
HRP20140344T1 (en) 2014-05-09
KR20100087346A (ko) 2010-08-04
JP5501245B2 (ja) 2014-05-21
CY1115168T1 (el) 2016-12-14
CN101889024A (zh) 2010-11-17
HK1144292A1 (en) 2011-02-11
ES2458315T7 (es) 2015-02-18
JP2011505414A (ja) 2011-02-24
KR101519840B1 (ko) 2015-05-18
EP2227488A1 (en) 2010-09-15
PT2227488E (pt) 2014-04-21
AU2008332968A1 (en) 2009-06-11
CN103709234A (zh) 2014-04-09
DK2227488T6 (en) 2015-02-16
HRP20140344T4 (hr) 2015-07-31
WO2009071886A1 (en) 2009-06-11
US8445448B2 (en) 2013-05-21
EA019370B1 (ru) 2014-03-31
EP2227488B3 (en) 2014-11-19
IL205780A (en) 2015-06-30
US20100323966A1 (en) 2010-12-23
CA2707559A1 (en) 2009-06-11
DK2227488T3 (da) 2014-04-22

Similar Documents

Publication Publication Date Title
PL3118220T3 (pl) Białko
GB0721686D0 (en) Polypeptides
AP2010005314A0 (en) Nanodispersian
EP2017283A4 (en) Peptides
ZA201000283B (en) Reinigung pegylierter polypeptide
ZA201001451B (en) Immunomodulatory peptides
IL202120A0 (en) Signaling peptides
GB0920981D0 (en) Peptides
PT2125871E (pt) Péptidos antibacterianos
EP2123666A4 (en) PEPTIDE
GB0719231D0 (en) Protein
GB0703945D0 (en) Peptide
GB0712302D0 (en) Chrondroitinase polypeptides
EP2136831A4 (en) ANTI-ANGIOGENIC PEPTIDES
GB0809659D0 (en) Polypeptides
GB0618748D0 (en) Peptide
GB0920987D0 (en) Peptides
IL197675A0 (en) Peptides
GB0708529D0 (en) Peptide standards
GB0605774D0 (en) Peptide
GB0817978D0 (en) Peptides
GB0720563D0 (en) Protein
DE602008004135D1 (en) Triphenylmethan- und xanthenpigmente
GB0705251D0 (en) Peptides
GB0705115D0 (en) Peptides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)